Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2-Negative Breast Cancer|Triple Negative Breast Cancer|Breast Cancer|Cancer of Breast|Breast Tumors
Interventions: DRUG: E7389 (Eribulin Mesylate)|DRUG: Vinorelbine injection
Sponsor: Eisai Co., Ltd.